This unique biosensing platform consists of an array of ultrathin graphene...
This unique biosensing platform consists of an array of ultrathin graphene layers and gold nanostructures. The platform, combined with high-tech imaging (Raman spectroscopy), detects genetic material (RNA) and characterizes different kinds of stem cells with greater reliability, selectivity and sensitivity than today’s biosensors.
Source: Letao Yang, KiBum Lee, Jin-Ho Lee and Sy-Tsong (Dean) Chueng

Biosensor may help guide treatment of Alzheimer’s

A Rutgers-led team has created better biosensor technology that may help lead to safe stem cell therapies for treating Alzheimer’s and Parkinson’s diseases and other neurological disorders.

The technology, which features a unique graphene and gold-based platform and high-tech imaging, monitors the fate of stem cells by detecting genetic material (RNA) involved in turning such cells into brain cells (neurons).

Stem cells can become many different types of cells. As a result, stem cell therapy shows promise for regenerative treatment of neurological disorders such as Alzheimer’s, Parkinson’s, stroke and spinal cord injury, with diseased cells needing replacement or repair. But characterizing stem cells and controlling their fate must be resolved before they could be used in treatments. The formation of tumors and uncontrolled transformation of stem cells remain key barriers.

“A critical challenge is ensuring high sensitivity and accuracy in detecting biomarkers – indicators such as modified genes or proteins – within the complex stem cell microenvironment,” said senior author KiBum Lee, a professor in the Department of Chemistry and Chemical Biology in the School of Arts and Sciences at Rutgers University–New Brunswick. “Our technology, which took four years to develop, has demonstrated great potential for analyzing a variety of interactions in stem cells.”

The team’s unique biosensing platform consists of an array of ultrathin graphene layers and gold nanostructures. The platform, combined with high-tech imaging (Raman spectroscopy), detects genes and characterizes different kinds of stem cells with greater reliability, selectivity and sensitivity than today’s biosensors.

The team believes the technology can benefit a range of applications. By developing simple, rapid and accurate sensing platforms, Lee’s group aims to facilitate treatment of neurological disorders through stem cell therapy.

Stem cells may become a renewable source of replacement cells and tissues to treat diseases including macular degeneration, spinal cord injury, stroke, burns, heart disease, diabetes, osteoarthritis and rheumatoid arthritis, according to the National Institutes of Health.

Subscribe to our newsletter

Related articles

Wearable stimulator to zap Alzheimer's disease

Wearable stimulator to zap Alzheimer's disease

Stimulating humans' sense of smell to prevent conditions such as Alzheimer's Disease is the focus of international research.

CRISPRoff offers unrivaled control of epigenetic inheritance

CRISPRoff offers unrivaled control of epigenetic inheritance

Scientists have figured out how to modify CRISPR’s basic architecture to extend its reach beyond the genome and into what’s known as the epigenome.

AI could crack the language of cancer

AI could crack the language of cancer

Powerful algorithms used by Netflix, Amazon and Facebook can ‘predict’ the biological language of cancer and neurodegenerative diseases like Alzheimer's.

Biosensor measures extracellular hydrogen peroxide concentrations

Biosensor measures extracellular hydrogen peroxide concentrations

Researchers have tested a sensor for measuring hydrogen peroxide concentrations near cell membranes. The sensor has the potential to become a tool for new cancer therapies.

Hydrogel injection may repair heart muscle damagage

Hydrogel injection may repair heart muscle damagage

Researchers have developed an injectable hydrogel that could help repair and prevent further damage to the heart muscle after a heart attack.

Breast cancer-on-a-chip tests immunotherapy drugs

Breast cancer-on-a-chip tests immunotherapy drugs

Researchers have successfully designed and tested a system for rapid testing of large numbers of potential immunotherapy drugs.

Nano-thin piezoelectrics advance wearables

Nano-thin piezoelectrics advance wearables

A new type of ultra-efficient, nano-thin material could advance self-powered electronics, wearable technologies and even deliver pacemakers powered by heart beats.

CRISPR to cure sickle cell disease

CRISPR to cure sickle cell disease

University of Illinois Chicago is one of the U.S. sites participating in clinical trials to cure severe red blood congenital diseases such as sickle cell anemia or Thalassemia by safely modifying the DNA of patients’ blood cells.

Chatbot may detect early dementia in time for intervention

Chatbot may detect early dementia in time for intervention

If Alzheimer's dementia is identified early, the decline in neural functioning can be stabilized or even curtailed in some cases.

Popular articles

Subscribe to Newsletter